Copyright Reports & Markets. All rights reserved.

Global Contraceptive Injectable Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032

Request for Sample of this report
Buy now

1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global Contraceptive Injectable Consumption Value by Type: 2021 Versus 2025 Versus 2032
    • 1.3.2 Long-Acting Contraception
    • 1.3.3 Short-Acting Contraception
  • 1.4 Market Analysis by Application
    • 1.4.1 Overview: Global Contraceptive Injectable Consumption Value by Application: 2021 Versus 2025 Versus 2032
    • 1.4.2 Male
    • 1.4.3 Female
  • 1.5 Global Contraceptive Injectable Market Size & Forecast
    • 1.5.1 Global Contraceptive Injectable Consumption Value (2021 & 2025 & 2032)
    • 1.5.2 Global Contraceptive Injectable Sales Quantity (2021-2032)
    • 1.5.3 Global Contraceptive Injectable Average Price (2021-2032)

2 Manufacturers Profiles

  • 2.1 Bayer AG
    • 2.1.1 Bayer AG Details
    • 2.1.2 Bayer AG Major Business
    • 2.1.3 Bayer AG Contraceptive Injectable Product and Services
    • 2.1.4 Bayer AG Contraceptive Injectable Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.1.5 Bayer AG Recent Developments/Updates
  • 2.2 China Resources Zizhu Pharmaceutical Co., Ltd. (CR Zizhu)
    • 2.2.1 China Resources Zizhu Pharmaceutical Co., Ltd. (CR Zizhu) Details
    • 2.2.2 China Resources Zizhu Pharmaceutical Co., Ltd. (CR Zizhu) Major Business
    • 2.2.3 China Resources Zizhu Pharmaceutical Co., Ltd. (CR Zizhu) Contraceptive Injectable Product and Services
    • 2.2.4 China Resources Zizhu Pharmaceutical Co., Ltd. (CR Zizhu) Contraceptive Injectable Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.2.5 China Resources Zizhu Pharmaceutical Co., Ltd. (CR Zizhu) Recent Developments/Updates
  • 2.3 Church & Dwight
    • 2.3.1 Church & Dwight Details
    • 2.3.2 Church & Dwight Major Business
    • 2.3.3 Church & Dwight Contraceptive Injectable Product and Services
    • 2.3.4 Church & Dwight Contraceptive Injectable Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.3.5 Church & Dwight Recent Developments/Updates
  • 2.4 Organon Group Of Companies
    • 2.4.1 Organon Group Of Companies Details
    • 2.4.2 Organon Group Of Companies Major Business
    • 2.4.3 Organon Group Of Companies Contraceptive Injectable Product and Services
    • 2.4.4 Organon Group Of Companies Contraceptive Injectable Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.4.5 Organon Group Of Companies Recent Developments/Updates
  • 2.5 Pfizer Inc.
    • 2.5.1 Pfizer Inc. Details
    • 2.5.2 Pfizer Inc. Major Business
    • 2.5.3 Pfizer Inc. Contraceptive Injectable Product and Services
    • 2.5.4 Pfizer Inc. Contraceptive Injectable Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.5.5 Pfizer Inc. Recent Developments/Updates
  • 2.6 Afaxys, Inc.
    • 2.6.1 Afaxys, Inc. Details
    • 2.6.2 Afaxys, Inc. Major Business
    • 2.6.3 Afaxys, Inc. Contraceptive Injectable Product and Services
    • 2.6.4 Afaxys, Inc. Contraceptive Injectable Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.6.5 Afaxys, Inc. Recent Developments/Updates
  • 2.7 Agile Therapeutics
    • 2.7.1 Agile Therapeutics Details
    • 2.7.2 Agile Therapeutics Major Business
    • 2.7.3 Agile Therapeutics Contraceptive Injectable Product and Services
    • 2.7.4 Agile Therapeutics Contraceptive Injectable Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.7.5 Agile Therapeutics Recent Developments/Updates
  • 2.8 Janssen Pharmaceuticals, Inc.
    • 2.8.1 Janssen Pharmaceuticals, Inc. Details
    • 2.8.2 Janssen Pharmaceuticals, Inc. Major Business
    • 2.8.3 Janssen Pharmaceuticals, Inc. Contraceptive Injectable Product and Services
    • 2.8.4 Janssen Pharmaceuticals, Inc. Contraceptive Injectable Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.8.5 Janssen Pharmaceuticals, Inc. Recent Developments/Updates
  • 2.9 Veru, Inc.
    • 2.9.1 Veru, Inc. Details
    • 2.9.2 Veru, Inc. Major Business
    • 2.9.3 Veru, Inc. Contraceptive Injectable Product and Services
    • 2.9.4 Veru, Inc. Contraceptive Injectable Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.9.5 Veru, Inc. Recent Developments/Updates

3 Competitive Environment: Contraceptive Injectable by Manufacturer

  • 3.1 Global Contraceptive Injectable Sales Quantity by Manufacturer (2021-2026)
  • 3.2 Global Contraceptive Injectable Revenue by Manufacturer (2021-2026)
  • 3.3 Global Contraceptive Injectable Average Price by Manufacturer (2021-2026)
  • 3.4 Market Share Analysis (2025)
    • 3.4.1 Producer Shipments of Contraceptive Injectable by Manufacturer Revenue ($MM) and Market Share (%): 2025
    • 3.4.2 Top 3 Contraceptive Injectable Manufacturer Market Share in 2025
    • 3.4.3 Top 6 Contraceptive Injectable Manufacturer Market Share in 2025
  • 3.5 Contraceptive Injectable Market: Overall Company Footprint Analysis
    • 3.5.1 Contraceptive Injectable Market: Region Footprint
    • 3.5.2 Contraceptive Injectable Market: Company Product Type Footprint
    • 3.5.3 Contraceptive Injectable Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global Contraceptive Injectable Market Size by Region
    • 4.1.1 Global Contraceptive Injectable Sales Quantity by Region (2021-2032)
    • 4.1.2 Global Contraceptive Injectable Consumption Value by Region (2021-2032)
    • 4.1.3 Global Contraceptive Injectable Average Price by Region (2021-2032)
  • 4.2 North America Contraceptive Injectable Consumption Value (2021-2032)
  • 4.3 Europe Contraceptive Injectable Consumption Value (2021-2032)
  • 4.4 Asia-Pacific Contraceptive Injectable Consumption Value (2021-2032)
  • 4.5 South America Contraceptive Injectable Consumption Value (2021-2032)
  • 4.6 Middle East & Africa Contraceptive Injectable Consumption Value (2021-2032)

5 Market Segment by Type

  • 5.1 Global Contraceptive Injectable Sales Quantity by Type (2021-2032)
  • 5.2 Global Contraceptive Injectable Consumption Value by Type (2021-2032)
  • 5.3 Global Contraceptive Injectable Average Price by Type (2021-2032)

6 Market Segment by Application

  • 6.1 Global Contraceptive Injectable Sales Quantity by Application (2021-2032)
  • 6.2 Global Contraceptive Injectable Consumption Value by Application (2021-2032)
  • 6.3 Global Contraceptive Injectable Average Price by Application (2021-2032)

7 North America

  • 7.1 North America Contraceptive Injectable Sales Quantity by Type (2021-2032)
  • 7.2 North America Contraceptive Injectable Sales Quantity by Application (2021-2032)
  • 7.3 North America Contraceptive Injectable Market Size by Country
    • 7.3.1 North America Contraceptive Injectable Sales Quantity by Country (2021-2032)
    • 7.3.2 North America Contraceptive Injectable Consumption Value by Country (2021-2032)
    • 7.3.3 United States Market Size and Forecast (2021-2032)
    • 7.3.4 Canada Market Size and Forecast (2021-2032)
    • 7.3.5 Mexico Market Size and Forecast (2021-2032)

8 Europe

  • 8.1 Europe Contraceptive Injectable Sales Quantity by Type (2021-2032)
  • 8.2 Europe Contraceptive Injectable Sales Quantity by Application (2021-2032)
  • 8.3 Europe Contraceptive Injectable Market Size by Country
    • 8.3.1 Europe Contraceptive Injectable Sales Quantity by Country (2021-2032)
    • 8.3.2 Europe Contraceptive Injectable Consumption Value by Country (2021-2032)
    • 8.3.3 Germany Market Size and Forecast (2021-2032)
    • 8.3.4 France Market Size and Forecast (2021-2032)
    • 8.3.5 United Kingdom Market Size and Forecast (2021-2032)
    • 8.3.6 Russia Market Size and Forecast (2021-2032)
    • 8.3.7 Italy Market Size and Forecast (2021-2032)

9 Asia-Pacific

  • 9.1 Asia-Pacific Contraceptive Injectable Sales Quantity by Type (2021-2032)
  • 9.2 Asia-Pacific Contraceptive Injectable Sales Quantity by Application (2021-2032)
  • 9.3 Asia-Pacific Contraceptive Injectable Market Size by Region
    • 9.3.1 Asia-Pacific Contraceptive Injectable Sales Quantity by Region (2021-2032)
    • 9.3.2 Asia-Pacific Contraceptive Injectable Consumption Value by Region (2021-2032)
    • 9.3.3 China Market Size and Forecast (2021-2032)
    • 9.3.4 Japan Market Size and Forecast (2021-2032)
    • 9.3.5 South Korea Market Size and Forecast (2021-2032)
    • 9.3.6 India Market Size and Forecast (2021-2032)
    • 9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
    • 9.3.8 Australia Market Size and Forecast (2021-2032)

10 South America

  • 10.1 South America Contraceptive Injectable Sales Quantity by Type (2021-2032)
  • 10.2 South America Contraceptive Injectable Sales Quantity by Application (2021-2032)
  • 10.3 South America Contraceptive Injectable Market Size by Country
    • 10.3.1 South America Contraceptive Injectable Sales Quantity by Country (2021-2032)
    • 10.3.2 South America Contraceptive Injectable Consumption Value by Country (2021-2032)
    • 10.3.3 Brazil Market Size and Forecast (2021-2032)
    • 10.3.4 Argentina Market Size and Forecast (2021-2032)

11 Middle East & Africa

  • 11.1 Middle East & Africa Contraceptive Injectable Sales Quantity by Type (2021-2032)
  • 11.2 Middle East & Africa Contraceptive Injectable Sales Quantity by Application (2021-2032)
  • 11.3 Middle East & Africa Contraceptive Injectable Market Size by Country
    • 11.3.1 Middle East & Africa Contraceptive Injectable Sales Quantity by Country (2021-2032)
    • 11.3.2 Middle East & Africa Contraceptive Injectable Consumption Value by Country (2021-2032)
    • 11.3.3 Turkey Market Size and Forecast (2021-2032)
    • 11.3.4 Egypt Market Size and Forecast (2021-2032)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
    • 11.3.6 South Africa Market Size and Forecast (2021-2032)

12 Market Dynamics

  • 12.1 Contraceptive Injectable Market Drivers
  • 12.2 Contraceptive Injectable Market Restraints
  • 12.3 Contraceptive Injectable Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

  • 13.1 Raw Material of Contraceptive Injectable and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of Contraceptive Injectable
  • 13.3 Contraceptive Injectable Production Process
  • 13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 Contraceptive Injectable Typical Distributors
  • 14.3 Contraceptive Injectable Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    According to our (Global Info Research) latest study, the global Contraceptive Injectable market size was valued at US$ million in 2025 and is forecast to a readjusted size of US$ million by 2032 with a CAGR of %during review period.
    This report is a detailed and comprehensive analysis for global Contraceptive Injectable market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
    Key Features:
    Global Contraceptive Injectable market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
    Global Contraceptive Injectable market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
    Global Contraceptive Injectable market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
    Global Contraceptive Injectable market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2021-2026
    The Primary Objectives in This Report Are:
    To determine the size of the total market opportunity of global and key countries
    To assess the growth potential for Contraceptive Injectable
    To forecast future growth in each product and end-use market
    To assess competitive factors affecting the marketplace
    This report profiles key players in the global Contraceptive Injectable market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Bayer AG, China Resources Zizhu Pharmaceutical Co., Ltd. (CR Zizhu), Church & Dwight, Organon Group Of Companies, Pfizer Inc., Afaxys, Inc., Agile Therapeutics, Janssen Pharmaceuticals, Inc., Veru, Inc., etc.
    This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
    Market Segmentation
    Contraceptive Injectable market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
    Market segment by Type
    Long-Acting Contraception
    Short-Acting Contraception
    Market segment by Application
    Male
    Female
    Major players covered
    Bayer AG
    China Resources Zizhu Pharmaceutical Co., Ltd. (CR Zizhu)
    Church & Dwight
    Organon Group Of Companies
    Pfizer Inc.
    Afaxys, Inc.
    Agile Therapeutics
    Janssen Pharmaceuticals, Inc.
    Veru, Inc.
    Market segment by region, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
    South America (Brazil, Argentina, Colombia, and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
    The content of the study subjects, includes a total of 15 chapters:
    Chapter 1, to describe Contraceptive Injectable product scope, market overview, market estimation caveats and base year.
    Chapter 2, to profile the top manufacturers of Contraceptive Injectable, with price, sales quantity, revenue, and global market share of Contraceptive Injectable from 2021 to 2026.
    Chapter 3, the Contraceptive Injectable competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
    Chapter 4, the Contraceptive Injectable breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
    Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
    Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Contraceptive Injectable market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
    Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
    Chapter 13, the key raw materials and key suppliers, and industry chain of Contraceptive Injectable.
    Chapter 14 and 15, to describe Contraceptive Injectable sales channel, distributors, customers, research findings and conclusion.

    Buy now